Trexquant Investment LP Galapagos Nv Transaction History

Trexquant Investment LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$37.4 - $44.52 $716,771 - $853,225	-19,165 Reduced 60.65%	12,434 $505,000
Q1 2023 May 15, 2023	BUY	$36.5 - $48.0 $1.15 Million - $1.52 Million	31,599 New	31,599 $1.22 Million
Q3 2022 Nov 14, 2022	BUY	$42.27 - $57.6 $543,634 - $740,793	12,861 New	12,861 $548,000
Q3 2021 Nov 12, 2021	SELL	$52.17 - $70.2 $205,497 - $276,517	-3,939 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$68.86 - $83.34 $271,239 - $328,276	3,939 New	3,939 $271,000
Q1 2021 May 13, 2021	SELL	$76.15 - $111.94 $168,291 - $247,387	-2,210 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$96.85 - $148.25 $214,038 - $327,632	2,210 New	2,210 $219,000
Q3 2020 Nov 06, 2020	SELL	$122.47 - $213.56 $506,903 - $883,924	-4,139 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$185.52 - $231.25 $420,017 - $523,550	-2,264 Reduced 35.36%	4,139 $817,000
Q1 2020 May 08, 2020	BUY	$143.0 - $274.03 $915,629 - $1.75 Million	6,403 New	6,403 $1.25 Million
Q1 2019 May 13, 2019	SELL	$89.61 - $117.78 $248,578 - $326,721	-2,774 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$87.81 - $110.65 $43,729 - $55,103	498 Added 21.88%	2,774 $254,000
Q3 2018 Nov 09, 2018	BUY	$90.63 - $120.22 $206,273 - $273,620	2,276 New	2,276 $256,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.87B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.